Bengaluru: Johnson & Johnson is getting ready a possible sale of its orthopedics unit, in a deal that might high $20 billion, with the corporate eyeing non-public fairness companies because the most certainly patrons, a source conversant in the matter instructed Reuters on Thursday.
The firm didn’t instantly reply to a Reuters request for remark.
J&J final 12 months mentioned it had deliberate to separate its orthopedics unit, generally known as DePuy Synthes, right into a standalone firm throughout the subsequent 18 to 24 months, marking its second main spinoff in two years because it sharpens give attention to higher-growth healthcare segments.
Bloomberg Information first reported on this improvement and mentioned J&J is assembling paperwork and financials for DePuy Synthes earlier than it meets with attainable patrons within the coming weeks, citing individuals conversant in the matter.
A number of giant non-public fairness companies are contemplating teaming as much as probably purchase out the unit, Bloomberg mentioned, including that the sale might additionally draw curiosity from rival medical gadget gamers.
J&J’s orthopedics unit makes hip, knee and shoulder implants, surgical devices and different merchandise and generated $9.3 billion in gross sales in 2025.
The corporate’s chief monetary officer, Joe Wolk, beforehand mentioned J&J was exploring a number of paths for the separation, with a major give attention to a tax-free spinoff, however remained open to different choices.
He had added that the separation course of was already underway, and doesn’t anticipate additional materials updates on the transaction till mid-2026.
(Reporting by Sabrina Valle and Sneha S Ok in Bengaluru; Enhancing by Maju Samuel)
Source link
#Johnson #Johnson #explores #billion #sale #orthopedics #unit #source
